2-amino-5-phosphonovalerate has been researched along with Cranial Nerve VII Injuries in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Világi, I | 1 |
| Bárdos, G | 1 |
| Dénes, K | 1 |
| Farkas, B | 1 |
| Friedrich, P | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Cranial Nerve VII Injuries
| Article | Year |
|---|---|
Enhancement of synaptic strength in the somatosensory cortex following nerve injury does not parallel behavioural alterations.
Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Dose-Response Relationship, Radiation; Elect | 2005 |